World Wires · story 31110 · official · 1 source(s)

SCHEDULE 13D/A: Orbimed Advisors Llc discloses a stake in ArriVent BioPharma, Inc.

Filed: 2026-10-08 AccNo: 0000947871-26-000931 Size: 33 KB

Open in the desk

Coverage

• SCHEDULE 13D/A: Orbimed Advisors Llc discloses a stake in ArriVent BioPharma, Inc. SEC EDGAR: Schedule 13D stakes · tier A · clear net · 2026-10-08 22:39 UTC

What this site indexes